ArticleFrontiers in oncology2022

A Fucosylated Glycopeptide as a Candidate Biomarker for Early Diagnosis of NASH Hepatocellular Carcinoma Using a Stepped HCD Method and PRM Evaluation.

Yu Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.